Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 44

    1.

    MUC2 protein expression status is useful in assessing the effects of hyperthermic intraperitoneal chemotherapy for peritoneal dissemination of colon cancer.

    Fujishima Y, Goi T, Kimura Y, Hirono Y, Katayama K, Yamaguchi A.

    Int J Oncol. 2012 Apr;40(4):960-4. doi: 10.3892/ijo.2012.1334. Epub 2012 Jan 16.

    PMID:
    22266876
    [PubMed - in process]
    2.

    Pien Tze Huang inhibits tumor cell proliferation and promotes apoptosis via suppressing the STAT3 pathway in a colorectal cancer mouse model.

    Zhuang Q, Hong F, Shen A, Zheng L, Zeng J, Lin W, Chen Y, Sferra TJ, Hong Z, Peng J.

    Int J Oncol. 2012 May;40(5):1569-74. doi: 10.3892/ijo.2012.1326. Epub 2012 Jan 3.

    PMID:
    22218594
    [PubMed - in process]
    3.

    Resveratrol induces apoptosis via ROS-triggered autophagy in human colon cancer cells.

    Miki H, Uehara N, Kimura A, Sasaki T, Yuri T, Yoshizawa K, Tsubura A.

    Int J Oncol. 2012 Apr;40(4):1020-8. doi: 10.3892/ijo.2012.1325. Epub 2012 Jan 3.

    PMID:
    22218562
    [PubMed - in process]
    4.

    Comparison of peptide cancer signatures identified by mass spectrometry in serum of patients with head and neck, lung and colorectal cancers: association with tumor progression.

    Pietrowska M, Polańska J, Suwiński R, Wideł M, Rutkowski T, Marczyk M, Domińczyk I, Ponge L, Marczak L, Polański A, Widłak P.

    Int J Oncol. 2012 Jan;40(1):148-56. doi: 10.3892/ijo.2011.1186. Epub 2011 Sep 5.

    PMID:
    21894432
    [PubMed - indexed for MEDLINE]
    5.

    Possible association of decreased NKG2D expression levels and suppression of the activity of natural killer cells in patients with colorectal cancer.

    Shen Y, Lu C, Tian W, Wang L, Cui B, Jiao Y, Ma C, Ju Y, Zhu L, Shao C, Liu X, Wang J, Zhang B, Lu Z.

    Int J Oncol. 2012 Apr;40(4):1285-90. doi: 10.3892/ijo.2011.1315. Epub 2011 Dec 22.

    PMID:
    22200673
    [PubMed - in process]
    6.

    Regional therapy with DTA-H19 vector suppresses growth of colon adenocarcinoma metastases in the rat liver.

    Sorin V, Ohana P, Mizrahi A, Matouk I, Birman T, Hochberg A, Czerniak A.

    Int J Oncol. 2011 Dec;39(6):1407-12. doi: 10.3892/ijo.2011.1171. Epub 2011 Aug 18.

    PMID:
    21874233
    [PubMed - indexed for MEDLINE]
    7.

    Two initiation sites of early detection of colon cancer, revealed by localization of pERK1/2 in the nuclei or in aggregates at the perinuclear region of tumor cells.

    Amsterdam A, Shezen E, Raanan C, Schreiber L, Slilat Y, Fabrikant Y, Melzer E, Seger R.

    Int J Oncol. 2012 Mar;40(3):782-8. doi: 10.3892/ijo.2011.1268. Epub 2011 Nov 22.

    PMID:
    22108866
    [PubMed - in process]
    8.

    Evaluation of CXCL10 as a novel serum marker for predicting liver metastasis and prognosis in colorectal cancer.

    Toiyama Y, Fujikawa H, Kawamura M, Matsushita K, Saigusa S, Tanaka K, Inoue Y, Uchida K, Mohri Y, Kusunoki M.

    Int J Oncol. 2012 Feb;40(2):560-6. doi: 10.3892/ijo.2011.1247. Epub 2011 Oct 31.

    PMID:
    22038159
    [PubMed - indexed for MEDLINE]
    9.

    Identification of GABRA1 and LAMA2 as new DNA methylation markers in colorectal cancer.

    Lee S, Oh T, Chung H, Rha S, Kim C, Moon Y, Hoehn BD, Jeong D, Lee S, Kim N, Park C, Yoo M, An S.

    Int J Oncol. 2012 Mar;40(3):889-98. doi: 10.3892/ijo.2011.1245. Epub 2011 Oct 25.

    PMID:
    22038115
    [PubMed - in process]
    10.

    Potential biological insights revealed by an integrated assessment of proteomic and transcriptomic data in human colorectal cancer.

    Takemasa I, Kittaka N, Hitora T, Watanabe M, Matsuo E, Mizushima T, Ikeda M, Yamamoto H, Sekimoto M, Nishimura O, Doki Y, Mori M.

    Int J Oncol. 2012 Feb;40(2):551-9. doi: 10.3892/ijo.2011.1244. Epub 2011 Oct 24.

    PMID:
    22025299
    [PubMed - indexed for MEDLINE]
    11.

    Detection of KRAS mutations in colorectal cancer with Fast COLD-PCR.

    Carotenuto P, Roma C, Cozzolino S, Fenizia F, Rachiglio AM, Tatangelo F, Iannaccone A, Baron L, Botti G, Normanno N.

    Int J Oncol. 2012 Feb;40(2):378-84. doi: 10.3892/ijo.2011.1221. Epub 2011 Oct 4.

    PMID:
    21971641
    [PubMed - indexed for MEDLINE]
    12.

    Heterogeneity of colorectal cancers and extraction of discriminator gene signatures for personalized prediction of prognosis.

    Miyake M, Takemasa I, Matoba R, Tanino M, Niijima S, Ikeda M, Yamamoto H, Sekimoto M, Kuhara S, Okayama T, Monden M, Matsubara K, Mori M.

    Int J Oncol. 2011 Oct;39(4):781-9. doi: 10.3892/ijo.2011.1092. Epub 2011 Jun 22.

    PMID:
    21701771
    [PubMed - indexed for MEDLINE]
    13.

    Anti-carcinogenic properties of omeprazole against human colon cancer cells and azoxymethane-induced colonic aberrant crypt foci formation in rats.

    Patlolla JM, Zhang Y, Li Q, Steele VE, Rao CV.

    Int J Oncol. 2012 Jan;40(1):170-5. doi: 10.3892/ijo.2011.1214. Epub 2011 Sep 28.

    PMID:
    21956158
    [PubMed - indexed for MEDLINE]
    14.

    Clinical significance of UNC5B expression in colorectal cancer.

    Okazaki S, Ishikawa T, Iida S, Ishiguro M, Kobayashi H, Higuchi T, Enomoto M, Mogushi K, Mizushima H, Tanaka H, Uetake H, Sugihara K.

    Int J Oncol. 2012 Jan;40(1):209-16. doi: 10.3892/ijo.2011.1201. Epub 2011 Sep 15.

    PMID:
    21922135
    [PubMed - indexed for MEDLINE]
    15.

    Identification of a potent epigenetic biomarker for resistance to camptothecin and poor outcome to irinotecan-based chemotherapy in colon cancer.

    Miyaki Y, Suzuki K, Koizumi K, Kato T, Saito M, Kamiyama H, Maeda T, Shibata K, Shiya N, Konishi F.

    Int J Oncol. 2012 Jan;40(1):217-26. doi: 10.3892/ijo.2011.1189. Epub 2011 Sep 7.

    PMID:
    21901246
    [PubMed - indexed for MEDLINE]
    16.

    The effect of a dimeric Affibody molecule (ZEGFR:1907)2 targeting EGFR in combination with radiation in colon cancer cell lines.

    Häggblad Sahlberg S, Spiegelberg D, Lennartsson J, Nygren P, Glimelius B, Stenerlöw B.

    Int J Oncol. 2012 Jan;40(1):176-84. doi: 10.3892/ijo.2011.1177. Epub 2011 Aug 29.

    PMID:
    21879255
    [PubMed - indexed for MEDLINE]
    17.

    Growth response of human colorectal tumour cell lines to treatment with afatinib (BIBW2992), an irreversible erbB family blocker, and its association with expression of HER family members.

    Khelwatty SA, Essapen S, Seddon AM, Modjtahedi H.

    Int J Oncol. 2011 Aug;39(2):483-91. doi: 10.3892/ijo.2011.1054. Epub 2011 May 25.

    PMID:
    21617858
    [PubMed - indexed for MEDLINE]
    18.

    Promoter methylation of leukemia inhibitory factor receptor gene in colorectal carcinoma.

    Cho YG, Chang X, Park IS, Yamashita K, Shao C, Ha PK, Pai SI, Sidransky D, Kim MS.

    Int J Oncol. 2011 Aug;39(2):337-44. doi: 10.3892/ijo.2011.1050. Epub 2011 May 23.

    PMID:
    21617854
    [PubMed - indexed for MEDLINE]
    19.

    Altered levels of the onco-microRNA 21 and the tumor-supressor microRNAs 143 and 145 in advanced rectal cancer indicate successful neoadjuvant chemoradiotherapy.

    Drebber U, Lay M, Wedemeyer I, Vallböhmer D, Bollschweiler E, Brabender J, Mönig SP, Hölscher AH, Dienes HP, Odenthal M.

    Int J Oncol. 2011 Aug;39(2):409-15. doi: 10.3892/ijo.2011.1036. Epub 2011 May 10.

    PMID:
    21567082
    [PubMed - indexed for MEDLINE]
    20.

    Herpesvirus saimiri-mediated delivery of the adenomatous polyposis coli tumour suppressor gene reduces proliferation of colorectal cancer cells.

    Macnab SA, Turrell SJ, Carr IM, Markham AF, Coletta PL, Whitehouse A.

    Int J Oncol. 2011 Nov;39(5):1173-81. doi: 10.3892/ijo.2011.1130. Epub 2011 Jul 18.

    PMID:
    21769429
    [PubMed - indexed for MEDLINE]

      Display Settings:

      Format
      Items per page
      Sort by

      Send to:

      Choose Destination

      Supplemental Content

      Find related data

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk